Skip to content
Open access · CC-BY via OpenAlex

Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model

Daniela Hartmann Jornada, Diogo Boreski, Diego Eidy Chiba, Denise Ligeiro, Marcus Alexandre Mendes Luz, Edmo Atique Gabriel, Cauê Benito Scarim, Cléverton Roberto de Andrade, Chung Man Chin

Nutrients · 2024 · ▲ 8 citations

Abstract

Colorectal cancer (CRC) is one of the top 10 most common cancers worldwide and caused approximately 10 million deaths in 2022. CRC mortality has increased by 10% since 2020 and 52.000 deaths will occur in 2024, highlighting the limitations of current treatments due to ineffectiveness, toxicity, or non-adherence. The widely used chemotherapeutic agent, 5-fluorouracil (5-FU), is associated with several adverse effects, including renal, cardiac, and hepatic toxicity; mucositis; and resistance. Taurine (TAU), an essential β-amino acid with potent antioxidant, antimutagenic, and anti-inflammatory properties, has demonstrated protective effects against tissue toxicity from chemotherapeutic agents like doxorubicin and cisplatin. Taurine deficiency is linked to aging and cancers such as breast and colon cancer. This study hypothesized that TAU may mitigate the adverse effects of 5-fluorouracil (5-FU). Carcinogenesis was chemically induced in rats using 1,2-dimethylhydrazine (DMH). Following five months of cancer progression, taurine (100 mg/kg) was administered orally for 8 days, and colon tissues were analyzed. The results showed 80% of adenocarcinoma (AC) in DMH-induced control animals. Notably, the efficacy of 5-FU showed 70% AC and TAU 50% while, in the 5-FU + TAU group, no adenocarcinoma was observed. No differences were observed in the inflammatory infiltrate or the expression of genes such as K-ras, p53, and Ki-67 among the cancer-induced groups whereas APC/β-catenin expression was increased in the 5FU + TAU-treated group. The mitotic index and dysplasia were increased in the induced 5-FU group and when associated with TAU, the levels returned to normal. These data suggest that 5-FU exhibits a synergic anticancer effect when combined with taurine.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/nu16183047
Canonical
link ↗
Fetched
2026-10-11 MST

Cite this

APA
Jornada, D.H., Boreski, D., Chiba, D.E., Ligeiro, D., Luz, M.A.M., Gabriel, E.A., Scarim, C.B., Andrade, C.R.D., &amp; Chin, C.M. (2024). Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model. <em>Nutrients</em>. https://doi.org/10.3390/nu16183047
Vancouver
Jornada DH, Boreski D, Chiba DE, Ligeiro D, Luz MAM, Gabriel EA, et al. Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model. Nutrients. 2024. doi:10.3390/nu16183047.
BibTeX
@article{daniela2024Synerg, title = {Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model}, author = {Daniela Hartmann Jornada and Diogo Boreski and Diego Eidy Chiba and Denise Ligeiro and Marcus Alexandre Mendes Luz and Edmo Atique Gabriel and Cauê Benito Scarim and Cléverton Roberto de Andrade and Chung Man Chin}, journal = {Nutrients}, year = {2024}, doi = {10.3390/nu16183047}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings